Nuveen Asset Management’s Avalo Therapeutics AVTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-141
| Closed | -$294K | – | 3242 |
|
|
2022
Q1 | $294K | Sell |
141
-65
| -32% | -$136K | ﹤0.01% | 3126 |
|
|
2021
Q4 | $1.01M | Sell |
206
-6
| -3% | -$29.4K | ﹤0.01% | 2860 |
|
|
2021
Q3 | $1.37M | Buy |
212
+92
| +77% | +$596K | ﹤0.01% | 2847 |
|
|
2021
Q2 | $1.13M | Buy |
120
+33
| +38% | +$310K | ﹤0.01% | 2965 |
|
|
2021
Q1 | $758K | Buy |
87
+27
| +45% | +$235K | ﹤0.01% | 2984 |
|
|
2020
Q4 | $457K | Buy |
60
+1
| +2% | +$7.62K | ﹤0.01% | 3059 |
|
|
2020
Q3 | $389K | Buy |
59
+5
| +9% | +$33K | ﹤0.01% | 3019 |
|
|
2020
Q2 | $402K | Buy |
54
+29
| +116% | +$216K | ﹤0.01% | 2974 |
|
|
2020
Q1 | $176K | Buy |
25
+5
| +25% | +$35.2K | ﹤0.01% | 3007 |
|
|
2019
Q4 | $310K | Hold |
20
| – | – | ﹤0.01% | 3001 |
|
|
2019
Q3 | $190K | Hold |
20
| – | – | ﹤0.01% | 3126 |
|
|
2019
Q2 | $313K | Buy |
+20
| New | +$313K | ﹤0.01% | 3099 |
|